Friday, May 23, 2025
22.1 C
Bengaluru

Opportunities for Indian Pharma

[wpfilebase tag=file id=75 tpl=download-button /]

Inside this Issue

1. Medical Rep to Country Head by Bhaskar Chakravorti
Bhaskar Chakravorti – Vice President, Micro Labs, talks about the growth of his career and his love for the country he presently calls ‘home’.

2. “Organizational Alignment Begins with a Common Vocabulary” by Hanno Wolfram
Our Editor Anup Soans sits down for a tête-à-tête with Hanno Wolfram – Owner, Innov8 and Member, MedicinMan Editorial Board.

3. Motivation: The No. 1 Challenge for Frontline Managers by K. Hariram
Motivation is created in teams only when ‘people’ and ‘purpose’ are prioritised.

4. A Pharma Technology Company Deeply Rooted in Experience by Krishna Singh
Krishna Singh spent 15 years in the Pharma Industry, beginning as a Medical Rep, before starting GlobalSpace technologies – a real Pharma field force multiplier.

5. Is Pharma Brand Management Promoting Mediocrity? by Shreenivas S
Simply hiring people because they have MBAs, without ascertaining their domain expertise or competency for the job, is a sure recipe for disaster. .

6. To Survive in the Jungle of Pharma Sales, Think like a Lion? by Chandan Kumar
Simple pointers to survive and thrive in the jungle of pharma sales.

7. Indian Pharma’s Many Challenges by Salil Kallianpur
The Indian Pharma Industry faces a multitude of challenges (and opportunities), some of which are unique to different sets of players, such as domestic Co’s and MNCs.

Hot this week

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?

Tata 1mg App Business Model: How does it work...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable...

Topics

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable...

Nimesulide – Nice or Not Nise?

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...
spot_img

Related Articles

spot_imgspot_img